Phase 2 Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You are in generally good physical condition and able to carry out everyday activities, and your doctor expects you to live at least 3 more months (confirm with trial site)
- You have been diagnosed with a specific stage of non-small cell lung cancer (stage IIB–IIIB) that has a particular genetic change in one of the following: RET, BRAF, ERBB2, MET, or related genes — confirmed by a lab test
- Your lungs are healthy enough to tolerate surgery
- A sample of your tumor tissue is available for testing
- You are willing to follow the study plan, attend follow-up visits, and have signed a consent form agreeing to take part
Who may not be able to join:
- Your lung cancer is at an early stage (stage I) or has spread widely to other parts of the body (stage IV)
- You have previously had any anti-cancer treatment or radiotherapy
- Your genetic test results show certain other specific mutations (such as EGFR, ALK, ROS1, or others combined with MDM2/MDM4 changes) (confirm with trial site)
- You have been diagnosed with small cell lung cancer, or a mixed type including small cell lung cancer
- You have had active bleeding in the 6 months before joining, are on blood-thinning or clot-dissolving medication, are coughing up blood, or have a condition that puts you at clear risk of bleeding in the digestive tract
- You have a serious underlying health condition — such as a significant heart, lung, or infection-related illness — or a digestive problem that could affect how your body absorbs medication (such as difficulty swallowing, chronic diarrhea, or bowel blockage), or you have had your entire stomach removed
- You have an active autoimmune disease (a condition where your immune system attacks your own body), unless it is a mild or well-controlled condition such as type 1 diabetes, an underactive thyroid managed with hormones, or a skin condition not needing systemic treatment
- You have active hepatitis B or hepatitis C
- You have HIV or AIDS
- You have had another active cancer within the last 5 years
- You are pregnant or breastfeeding, or you are able to have children but are unwilling or unable to use effective contraception during the study
- You are unlikely to follow the treatment plan or attend required check-ups
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 02083827812
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathological Complete Response (pCR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.